SynthesisBMC rheumatology2026
Associations between interleukin-37 gene polymorphisms and susceptibility and clinical outcomes of rheumatoid arthritis: a meta-analysis and systematic review.
Synthesis in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) is a chronic autoimmune disease affecting millions of people worldwide. Genetic factors, including specific polymorphisms such as the anti-inflammatory cytokine Interleukin (IL)-37, play a significant role in RA. This meta-analysis and systematic review investigated the associations between IL-37 gene polymorphisms and susceptibility and clinical outcomes of RA.
methodsA comprehensive literature search of the MEDLINE(R), Embase, and Web of Science databases was conducted on January 1, 2026. Case control studies assessing associations between IL-37 polymorphisms and RA susceptibility and/or clinical outcomes were included. Studies deviating from the Hardy-Weinberg equilibrium in controls, lacking genotype data, reviews, duplicates, or non-original studies were excluded. Study selection, data extraction, and quality assessment using the Newcastle-Ottawa Scale were independently performed by two authors, with any discrepancies resolved by a senior researcher. Data were pooled using inverse-variance weighted random-effects models under five genetic models, with heterogeneity assessed using Cochran’s Q test and the I2 statistic. Sensitivity analyses were conducted, and prediction intervals were calculated.
resultsA total of 7 studies were included in the final analysis, involving 1627 RA patients and 1722 healthy controls. No significant associations were observed between IL-37 polymorphisms (including rs3811047 and rs3811046) and RA susceptibility across genetic models. In the dominant model of rs3811047, patients carrying the AA or AG genotypes exhibit favorable clinical outcomes as compared to patients having GG genotype, including lower joint swelling index scores (MD = −1.65, 95% CI −2.53 to −0.78, p = 0.0002), reduced rest pain (MD = −1.02, 95% CI −1.52 to −0.52, p < 0.0001), lower joint tenderness index scores (MD = −2.11, 95% CI −3.96 to −0.27, p = 0.02), and improved Health Assessment Questionnaire scores (MD = −0.28, 95% CI −0.42 to −0.15, p < 0.0001).
conclusionIL-37 polymorphisms do not appear to be strongly associated with RA susceptibility but may influence disease severity, highlighting a potential role in RA pathophysiology and prognosis. Limitations included a small number of included studies, moderate to high heterogeneity in some genetic models, and limited availability of genotype-stratified clinical outcome data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.